Global Biobanking Supply, Demand and Key Producers, 2026-2032
The global Biobanking market size is expected to reach $ 5751 million by 2032, rising at a market growth of 6.7% CAGR during the forecast period (2026-2032).
Biobanking is the end-to-end infrastructure and operating system that manages biospecimens and their associated data across the full life cycle—standardized collection, processing, quality control, aliquoting, storage, traceability, and compliant access. It covers human and non-human samples (e.g., blood, tissue, cells, DNA/RNA, and other biofluids) and integrates clinical phenotypes, longitudinal follow-up, omics outputs, and metadata under a single governance and quality framework.
Multi-omics, precision medicine, and translational R&D are pushing demand for high-quality, reusable, and traceable specimens that can withstand stringent analytical and regulatory expectations. As clinical development increasingly relies on biomarker-guided stratification and companion diagnostics, biobanks are evolving from local repositories into collaborative platforms that enable cross-site studies and consistent evidence generation. Maturing global quality and best-practice frameworks further accelerate institutional adoption by formalizing competence, process control, and governance expectations. Key constraints concentrate on compliance, consistency, and operational resilience. Divergent interpretations around secondary use, broad consent, and research exemptions can complicate multi-country collaboration and data sharing; variability in pre-analytics, freeze–thaw handling, and metadata completeness can undermine reproducibility and reduce the scientific value of collections. On the operational side, ultra-low-temperature infrastructure, liquid-nitrogen safety, redundancy planning, and incident response are essential to prevent irreversible loss of specimen integrity and institutional trust. Demand is shifting from “store samples” to “deliver evidence”: biopharma seeks collections that are directly usable for biomarker discovery, patient stratification, and diagnostic development; hospitals and academia emphasize cohort building, longitudinal follow-up, and multi-center sharing; CROs and testing labs require stronger traceability and standardized data interfaces. In parallel, dynamic consent models, auditable governance, privacy-enhancing approaches, and federated collaboration patterns are gaining momentum as pathways to scale access while maintaining compliance and participant trust. The upstream stack combines consumables, cold-chain hardware, digital systems, and services. Core consumables include cryovials/cryobags, 2D-barcode labels and printing materials, racks/boxes, aliquoting tools, and stabilization buffers. Critical equipment spans ultra-low-temperature freezers, liquid-nitrogen storage, automated aliquoting and retrieval robotics, environmental monitoring and alarm sensors, backup power, and cold-chain transport tools. On the digital side, LIMS and specimen-management platforms—plus identity/access control, audit trails, and system integration—are increasingly central as biobanking converges toward automation, traceability, and compliance-ready operations.
This report studies the global Biobanking demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biobanking, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biobanking that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biobanking total market, 2021-2032, (USD Million)
Global Biobanking total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Biobanking total market, key domestic companies, and share, (USD Million)
Global Biobanking revenue by player, revenue and market share 2021-2026, (USD Million)
Global Biobanking total market by Type, CAGR, 2021-2032, (USD Million)
Global Biobanking total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Biobanking market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Kryosphere, Precision for Medicine, Azenta, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biobanking market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biobanking Market, By Region:
1. How big is the global Biobanking market?
2. What is the demand of the global Biobanking market?
3. What is the year over year growth of the global Biobanking market?
4. What is the total value of the global Biobanking market?
5. Who are the Major Players in the global Biobanking market?
6. What are the growth factors driving the market demand?
Biobanking is the end-to-end infrastructure and operating system that manages biospecimens and their associated data across the full life cycle—standardized collection, processing, quality control, aliquoting, storage, traceability, and compliant access. It covers human and non-human samples (e.g., blood, tissue, cells, DNA/RNA, and other biofluids) and integrates clinical phenotypes, longitudinal follow-up, omics outputs, and metadata under a single governance and quality framework.
Multi-omics, precision medicine, and translational R&D are pushing demand for high-quality, reusable, and traceable specimens that can withstand stringent analytical and regulatory expectations. As clinical development increasingly relies on biomarker-guided stratification and companion diagnostics, biobanks are evolving from local repositories into collaborative platforms that enable cross-site studies and consistent evidence generation. Maturing global quality and best-practice frameworks further accelerate institutional adoption by formalizing competence, process control, and governance expectations. Key constraints concentrate on compliance, consistency, and operational resilience. Divergent interpretations around secondary use, broad consent, and research exemptions can complicate multi-country collaboration and data sharing; variability in pre-analytics, freeze–thaw handling, and metadata completeness can undermine reproducibility and reduce the scientific value of collections. On the operational side, ultra-low-temperature infrastructure, liquid-nitrogen safety, redundancy planning, and incident response are essential to prevent irreversible loss of specimen integrity and institutional trust. Demand is shifting from “store samples” to “deliver evidence”: biopharma seeks collections that are directly usable for biomarker discovery, patient stratification, and diagnostic development; hospitals and academia emphasize cohort building, longitudinal follow-up, and multi-center sharing; CROs and testing labs require stronger traceability and standardized data interfaces. In parallel, dynamic consent models, auditable governance, privacy-enhancing approaches, and federated collaboration patterns are gaining momentum as pathways to scale access while maintaining compliance and participant trust. The upstream stack combines consumables, cold-chain hardware, digital systems, and services. Core consumables include cryovials/cryobags, 2D-barcode labels and printing materials, racks/boxes, aliquoting tools, and stabilization buffers. Critical equipment spans ultra-low-temperature freezers, liquid-nitrogen storage, automated aliquoting and retrieval robotics, environmental monitoring and alarm sensors, backup power, and cold-chain transport tools. On the digital side, LIMS and specimen-management platforms—plus identity/access control, audit trails, and system integration—are increasingly central as biobanking converges toward automation, traceability, and compliance-ready operations.
This report studies the global Biobanking demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Biobanking, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2025 as the base year. This report explores demand trends and competition, as well as details the characteristics of Biobanking that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Biobanking total market, 2021-2032, (USD Million)
Global Biobanking total market by region & country, CAGR, 2021-2032, (USD Million)
U.S. VS China: Biobanking total market, key domestic companies, and share, (USD Million)
Global Biobanking revenue by player, revenue and market share 2021-2026, (USD Million)
Global Biobanking total market by Type, CAGR, 2021-2032, (USD Million)
Global Biobanking total market by Application, CAGR, 2021-2032, (USD Million)
This report profiles major players in the global Biobanking market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Kryosphere, Precision for Medicine, Azenta, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the world Biobanking market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2021-2032 by year with 2025 as the base year, 2026 as the estimate year, and 2027-2032 as the forecast year.
Global Biobanking Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Blood
- Tissue
- Cells
- Other
- Ambient
- 2–8°C Refrigerated
- -20°C Freezer
- -80°C ULT
- Other
- Oncology
- Immunology
- Infectious Disease
- Public Health
- Metabolic
- Other
- Life Sciences and Medicine
- Hospitals
- Research Institutions
- Other
- Thermo Fisher
- Beckman Coulter
- Panasonic
- SOL Group
- Promega
- Merck
- Greiner Bio One
- Kryosphere
- Precision for Medicine
- Azenta
- QIAGEN
- Vigilant Bioservices
- Lifeline Scientific
- Masy BioServices
1. How big is the global Biobanking market?
2. What is the demand of the global Biobanking market?
3. What is the year over year growth of the global Biobanking market?
4. What is the total value of the global Biobanking market?
5. Who are the Major Players in the global Biobanking market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Biobanking Introduction
1.2 World Biobanking Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biobanking Total Market by Region (by Headquarter Location)
1.3.1 World Biobanking Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biobanking Revenue (2021-2032)
1.3.3 China Based Company Biobanking Revenue (2021-2032)
1.3.4 Europe Based Company Biobanking Revenue (2021-2032)
1.3.5 Japan Based Company Biobanking Revenue (2021-2032)
1.3.6 South Korea Based Company Biobanking Revenue (2021-2032)
1.3.7 ASEAN Based Company Biobanking Revenue (2021-2032)
1.3.8 India Based Company Biobanking Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biobanking Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biobanking Consumption Value (2021-2032)
2.2 World Biobanking Consumption Value by Region
2.2.1 World Biobanking Consumption Value by Region (2021-2026)
2.2.2 World Biobanking Consumption Value Forecast by Region (2027-2032)
2.3 United States Biobanking Consumption Value (2021-2032)
2.4 China Biobanking Consumption Value (2021-2032)
2.5 Europe Biobanking Consumption Value (2021-2032)
2.6 Japan Biobanking Consumption Value (2021-2032)
2.7 South Korea Biobanking Consumption Value (2021-2032)
2.8 ASEAN Biobanking Consumption Value (2021-2032)
2.9 India Biobanking Consumption Value (2021-2032)
3 WORLD BIOBANKING COMPANIES COMPETITIVE ANALYSIS
3.1 World Biobanking Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biobanking Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biobanking in 2025
3.2.3 Global Concentration Ratios (CR8) for Biobanking in 2025
3.3 Biobanking Company Evaluation Quadrant
3.4 Biobanking Market: Overall Company Footprint Analysis
3.4.1 Biobanking Market: Region Footprint
3.4.2 Biobanking Market: Company Product Type Footprint
3.4.3 Biobanking Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biobanking Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biobanking Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biobanking Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biobanking Consumption Value Comparison
4.2.1 United States VS China: Biobanking Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biobanking Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biobanking Companies and Market Share, 2021-2026
4.3.1 United States Based Biobanking Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biobanking Revenue, (2021-2026)
4.4 China Based Companies Biobanking Revenue and Market Share, 2021-2026
4.4.1 China Based Biobanking Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biobanking Revenue, (2021-2026)
4.5 Rest of World Based Biobanking Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biobanking Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biobanking Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biobanking Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood
5.2.2 Tissue
5.2.3 Cells
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biobanking Market Size by Type (2021-2026)
5.3.2 World Biobanking Market Size by Type (2027-2032)
5.3.3 World Biobanking Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY STORAGE TEMPERATURE TIER
6.1 World Biobanking Market Size Overview by Storage Temperature Tier: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Storage Temperature Tier
6.2.1 Ambient
6.2.2 2–8°C Refrigerated
6.2.3 -20°C Freezer
6.2.4 -80°C ULT
6.2.5 Other
6.3 Market Segment by Storage Temperature Tier
6.3.1 World Biobanking Market Size by Storage Temperature Tier (2021-2026)
6.3.2 World Biobanking Market Size by Storage Temperature Tier (2027-2032)
6.3.3 World Biobanking Market Size Market Share by Storage Temperature Tier (2027-2032)
7 MARKET ANALYSIS BY RESEARCH FOCUS
7.1 World Biobanking Market Size Overview by Research Focus: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Research Focus
7.2.1 Oncology
7.2.2 Immunology
7.2.3 Infectious Disease
7.2.4 Public Health
7.2.5 Metabolic
7.2.6 Other
7.3 Market Segment by Research Focus
7.3.1 World Biobanking Market Size by Research Focus (2021-2026)
7.3.2 World Biobanking Market Size by Research Focus (2027-2032)
7.3.3 World Biobanking Market Size Market Share by Research Focus (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Biobanking Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Life Sciences and Medicine
8.2.2 Hospitals
8.2.3 Research Institutions
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Biobanking Market Size by Application (2021-2026)
8.3.2 World Biobanking Market Size by Application (2027-2032)
8.3.3 World Biobanking Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher
9.1.1 Thermo Fisher Details
9.1.2 Thermo Fisher Major Business
9.1.3 Thermo Fisher Biobanking Product and Services
9.1.4 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Recent Developments/Updates
9.1.6 Thermo Fisher Competitive Strengths & Weaknesses
9.2 Beckman Coulter
9.2.1 Beckman Coulter Details
9.2.2 Beckman Coulter Major Business
9.2.3 Beckman Coulter Biobanking Product and Services
9.2.4 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Beckman Coulter Recent Developments/Updates
9.2.6 Beckman Coulter Competitive Strengths & Weaknesses
9.3 Panasonic
9.3.1 Panasonic Details
9.3.2 Panasonic Major Business
9.3.3 Panasonic Biobanking Product and Services
9.3.4 Panasonic Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Panasonic Recent Developments/Updates
9.3.6 Panasonic Competitive Strengths & Weaknesses
9.4 SOL Group
9.4.1 SOL Group Details
9.4.2 SOL Group Major Business
9.4.3 SOL Group Biobanking Product and Services
9.4.4 SOL Group Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 SOL Group Recent Developments/Updates
9.4.6 SOL Group Competitive Strengths & Weaknesses
9.5 Promega
9.5.1 Promega Details
9.5.2 Promega Major Business
9.5.3 Promega Biobanking Product and Services
9.5.4 Promega Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Promega Recent Developments/Updates
9.5.6 Promega Competitive Strengths & Weaknesses
9.6 Merck
9.6.1 Merck Details
9.6.2 Merck Major Business
9.6.3 Merck Biobanking Product and Services
9.6.4 Merck Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Merck Recent Developments/Updates
9.6.6 Merck Competitive Strengths & Weaknesses
9.7 Greiner Bio One
9.7.1 Greiner Bio One Details
9.7.2 Greiner Bio One Major Business
9.7.3 Greiner Bio One Biobanking Product and Services
9.7.4 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Greiner Bio One Recent Developments/Updates
9.7.6 Greiner Bio One Competitive Strengths & Weaknesses
9.8 Kryosphere
9.8.1 Kryosphere Details
9.8.2 Kryosphere Major Business
9.8.3 Kryosphere Biobanking Product and Services
9.8.4 Kryosphere Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Kryosphere Recent Developments/Updates
9.8.6 Kryosphere Competitive Strengths & Weaknesses
9.9 Precision for Medicine
9.9.1 Precision for Medicine Details
9.9.2 Precision for Medicine Major Business
9.9.3 Precision for Medicine Biobanking Product and Services
9.9.4 Precision for Medicine Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Precision for Medicine Recent Developments/Updates
9.9.6 Precision for Medicine Competitive Strengths & Weaknesses
9.10 Azenta
9.10.1 Azenta Details
9.10.2 Azenta Major Business
9.10.3 Azenta Biobanking Product and Services
9.10.4 Azenta Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Azenta Recent Developments/Updates
9.10.6 Azenta Competitive Strengths & Weaknesses
9.11 QIAGEN
9.11.1 QIAGEN Details
9.11.2 QIAGEN Major Business
9.11.3 QIAGEN Biobanking Product and Services
9.11.4 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 QIAGEN Recent Developments/Updates
9.11.6 QIAGEN Competitive Strengths & Weaknesses
9.12 Vigilant Bioservices
9.12.1 Vigilant Bioservices Details
9.12.2 Vigilant Bioservices Major Business
9.12.3 Vigilant Bioservices Biobanking Product and Services
9.12.4 Vigilant Bioservices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Vigilant Bioservices Recent Developments/Updates
9.12.6 Vigilant Bioservices Competitive Strengths & Weaknesses
9.13 Lifeline Scientific
9.13.1 Lifeline Scientific Details
9.13.2 Lifeline Scientific Major Business
9.13.3 Lifeline Scientific Biobanking Product and Services
9.13.4 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Lifeline Scientific Recent Developments/Updates
9.13.6 Lifeline Scientific Competitive Strengths & Weaknesses
9.14 Masy BioServices
9.14.1 Masy BioServices Details
9.14.2 Masy BioServices Major Business
9.14.3 Masy BioServices Biobanking Product and Services
9.14.4 Masy BioServices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Masy BioServices Recent Developments/Updates
9.14.6 Masy BioServices Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Biobanking Industry Chain
10.2 Biobanking Upstream Analysis
10.3 Biobanking Midstream Analysis
10.4 Biobanking Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
1.1 Biobanking Introduction
1.2 World Biobanking Market Size & Forecast (2021 & 2025 & 2032)
1.3 World Biobanking Total Market by Region (by Headquarter Location)
1.3.1 World Biobanking Market Size by Region (2021-2032), (by Headquarter Location)
1.3.2 United States Based Company Biobanking Revenue (2021-2032)
1.3.3 China Based Company Biobanking Revenue (2021-2032)
1.3.4 Europe Based Company Biobanking Revenue (2021-2032)
1.3.5 Japan Based Company Biobanking Revenue (2021-2032)
1.3.6 South Korea Based Company Biobanking Revenue (2021-2032)
1.3.7 ASEAN Based Company Biobanking Revenue (2021-2032)
1.3.8 India Based Company Biobanking Revenue (2021-2032)
1.4 Market Drivers, Restraints and Trends
1.4.1 Biobanking Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Major Market Trends
2 DEMAND SUMMARY
2.1 World Biobanking Consumption Value (2021-2032)
2.2 World Biobanking Consumption Value by Region
2.2.1 World Biobanking Consumption Value by Region (2021-2026)
2.2.2 World Biobanking Consumption Value Forecast by Region (2027-2032)
2.3 United States Biobanking Consumption Value (2021-2032)
2.4 China Biobanking Consumption Value (2021-2032)
2.5 Europe Biobanking Consumption Value (2021-2032)
2.6 Japan Biobanking Consumption Value (2021-2032)
2.7 South Korea Biobanking Consumption Value (2021-2032)
2.8 ASEAN Biobanking Consumption Value (2021-2032)
2.9 India Biobanking Consumption Value (2021-2032)
3 WORLD BIOBANKING COMPANIES COMPETITIVE ANALYSIS
3.1 World Biobanking Revenue by Player (2021-2026)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Biobanking Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Biobanking in 2025
3.2.3 Global Concentration Ratios (CR8) for Biobanking in 2025
3.3 Biobanking Company Evaluation Quadrant
3.4 Biobanking Market: Overall Company Footprint Analysis
3.4.1 Biobanking Market: Region Footprint
3.4.2 Biobanking Market: Company Product Type Footprint
3.4.3 Biobanking Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers & Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Biobanking Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Biobanking Revenue Comparison (2021 & 2025 & 2032) (by Headquarter Location)
4.1.2 United States VS China: Biobanking Revenue Market Share Comparison (2021 & 2025 & 2032)
4.2 United States Based Companies VS China Based Companies: Biobanking Consumption Value Comparison
4.2.1 United States VS China: Biobanking Consumption Value Comparison (2021 & 2025 & 2032)
4.2.2 United States VS China: Biobanking Consumption Value Market Share Comparison (2021 & 2025 & 2032)
4.3 United States Based Biobanking Companies and Market Share, 2021-2026
4.3.1 United States Based Biobanking Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Biobanking Revenue, (2021-2026)
4.4 China Based Companies Biobanking Revenue and Market Share, 2021-2026
4.4.1 China Based Biobanking Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Biobanking Revenue, (2021-2026)
4.5 Rest of World Based Biobanking Companies and Market Share, 2021-2026
4.5.1 Rest of World Based Biobanking Companies, Headquarters (Province, Country)
4.5.2 Rest of World Based Companies Biobanking Revenue (2021-2026)
5 MARKET ANALYSIS BY TYPE
5.1 World Biobanking Market Size Overview by Type: 2021 VS 2025 VS 2032
5.2 Segment Introduction by Type
5.2.1 Blood
5.2.2 Tissue
5.2.3 Cells
5.2.4 Other
5.3 Market Segment by Type
5.3.1 World Biobanking Market Size by Type (2021-2026)
5.3.2 World Biobanking Market Size by Type (2027-2032)
5.3.3 World Biobanking Market Size Market Share by Type (2027-2032)
6 MARKET ANALYSIS BY STORAGE TEMPERATURE TIER
6.1 World Biobanking Market Size Overview by Storage Temperature Tier: 2021 VS 2025 VS 2032
6.2 Segment Introduction by Storage Temperature Tier
6.2.1 Ambient
6.2.2 2–8°C Refrigerated
6.2.3 -20°C Freezer
6.2.4 -80°C ULT
6.2.5 Other
6.3 Market Segment by Storage Temperature Tier
6.3.1 World Biobanking Market Size by Storage Temperature Tier (2021-2026)
6.3.2 World Biobanking Market Size by Storage Temperature Tier (2027-2032)
6.3.3 World Biobanking Market Size Market Share by Storage Temperature Tier (2027-2032)
7 MARKET ANALYSIS BY RESEARCH FOCUS
7.1 World Biobanking Market Size Overview by Research Focus: 2021 VS 2025 VS 2032
7.2 Segment Introduction by Research Focus
7.2.1 Oncology
7.2.2 Immunology
7.2.3 Infectious Disease
7.2.4 Public Health
7.2.5 Metabolic
7.2.6 Other
7.3 Market Segment by Research Focus
7.3.1 World Biobanking Market Size by Research Focus (2021-2026)
7.3.2 World Biobanking Market Size by Research Focus (2027-2032)
7.3.3 World Biobanking Market Size Market Share by Research Focus (2027-2032)
8 MARKET ANALYSIS BY APPLICATION
8.1 World Biobanking Market Size Overview by Application: 2021 VS 2025 VS 2032
8.2 Segment Introduction by Application
8.2.1 Life Sciences and Medicine
8.2.2 Hospitals
8.2.3 Research Institutions
8.2.4 Other
8.3 Market Segment by Application
8.3.1 World Biobanking Market Size by Application (2021-2026)
8.3.2 World Biobanking Market Size by Application (2027-2032)
8.3.3 World Biobanking Market Size Market Share by Application (2021-2032)
9 COMPANY PROFILES
9.1 Thermo Fisher
9.1.1 Thermo Fisher Details
9.1.2 Thermo Fisher Major Business
9.1.3 Thermo Fisher Biobanking Product and Services
9.1.4 Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.1.5 Thermo Fisher Recent Developments/Updates
9.1.6 Thermo Fisher Competitive Strengths & Weaknesses
9.2 Beckman Coulter
9.2.1 Beckman Coulter Details
9.2.2 Beckman Coulter Major Business
9.2.3 Beckman Coulter Biobanking Product and Services
9.2.4 Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.2.5 Beckman Coulter Recent Developments/Updates
9.2.6 Beckman Coulter Competitive Strengths & Weaknesses
9.3 Panasonic
9.3.1 Panasonic Details
9.3.2 Panasonic Major Business
9.3.3 Panasonic Biobanking Product and Services
9.3.4 Panasonic Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.3.5 Panasonic Recent Developments/Updates
9.3.6 Panasonic Competitive Strengths & Weaknesses
9.4 SOL Group
9.4.1 SOL Group Details
9.4.2 SOL Group Major Business
9.4.3 SOL Group Biobanking Product and Services
9.4.4 SOL Group Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.4.5 SOL Group Recent Developments/Updates
9.4.6 SOL Group Competitive Strengths & Weaknesses
9.5 Promega
9.5.1 Promega Details
9.5.2 Promega Major Business
9.5.3 Promega Biobanking Product and Services
9.5.4 Promega Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.5.5 Promega Recent Developments/Updates
9.5.6 Promega Competitive Strengths & Weaknesses
9.6 Merck
9.6.1 Merck Details
9.6.2 Merck Major Business
9.6.3 Merck Biobanking Product and Services
9.6.4 Merck Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.6.5 Merck Recent Developments/Updates
9.6.6 Merck Competitive Strengths & Weaknesses
9.7 Greiner Bio One
9.7.1 Greiner Bio One Details
9.7.2 Greiner Bio One Major Business
9.7.3 Greiner Bio One Biobanking Product and Services
9.7.4 Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.7.5 Greiner Bio One Recent Developments/Updates
9.7.6 Greiner Bio One Competitive Strengths & Weaknesses
9.8 Kryosphere
9.8.1 Kryosphere Details
9.8.2 Kryosphere Major Business
9.8.3 Kryosphere Biobanking Product and Services
9.8.4 Kryosphere Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.8.5 Kryosphere Recent Developments/Updates
9.8.6 Kryosphere Competitive Strengths & Weaknesses
9.9 Precision for Medicine
9.9.1 Precision for Medicine Details
9.9.2 Precision for Medicine Major Business
9.9.3 Precision for Medicine Biobanking Product and Services
9.9.4 Precision for Medicine Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.9.5 Precision for Medicine Recent Developments/Updates
9.9.6 Precision for Medicine Competitive Strengths & Weaknesses
9.10 Azenta
9.10.1 Azenta Details
9.10.2 Azenta Major Business
9.10.3 Azenta Biobanking Product and Services
9.10.4 Azenta Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.10.5 Azenta Recent Developments/Updates
9.10.6 Azenta Competitive Strengths & Weaknesses
9.11 QIAGEN
9.11.1 QIAGEN Details
9.11.2 QIAGEN Major Business
9.11.3 QIAGEN Biobanking Product and Services
9.11.4 QIAGEN Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.11.5 QIAGEN Recent Developments/Updates
9.11.6 QIAGEN Competitive Strengths & Weaknesses
9.12 Vigilant Bioservices
9.12.1 Vigilant Bioservices Details
9.12.2 Vigilant Bioservices Major Business
9.12.3 Vigilant Bioservices Biobanking Product and Services
9.12.4 Vigilant Bioservices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.12.5 Vigilant Bioservices Recent Developments/Updates
9.12.6 Vigilant Bioservices Competitive Strengths & Weaknesses
9.13 Lifeline Scientific
9.13.1 Lifeline Scientific Details
9.13.2 Lifeline Scientific Major Business
9.13.3 Lifeline Scientific Biobanking Product and Services
9.13.4 Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.13.5 Lifeline Scientific Recent Developments/Updates
9.13.6 Lifeline Scientific Competitive Strengths & Weaknesses
9.14 Masy BioServices
9.14.1 Masy BioServices Details
9.14.2 Masy BioServices Major Business
9.14.3 Masy BioServices Biobanking Product and Services
9.14.4 Masy BioServices Biobanking Revenue, Gross Margin and Market Share (2021-2026)
9.14.5 Masy BioServices Recent Developments/Updates
9.14.6 Masy BioServices Competitive Strengths & Weaknesses
10 INDUSTRY CHAIN ANALYSIS
10.1 Biobanking Industry Chain
10.2 Biobanking Upstream Analysis
10.3 Biobanking Midstream Analysis
10.4 Biobanking Downstream Analysis
11 RESEARCH FINDINGS AND CONCLUSION
12 APPENDIX
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
LIST OF TABLES
Table 1. World Biobanking Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biobanking Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biobanking Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biobanking Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biobanking Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biobanking Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biobanking Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biobanking Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biobanking Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biobanking Players in 2025
Table 12. World Biobanking Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biobanking Company Evaluation Quadrant
Table 14. Head Office of Key Biobanking Players
Table 15. Biobanking Market: Company Product Type Footprint
Table 16. Biobanking Market: Company Product Application Footprint
Table 17. Biobanking Mergers & Acquisitions Activity
Table 18. United States VS China Biobanking Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biobanking Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biobanking Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biobanking Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biobanking Revenue Market Share (2021-2026)
Table 23. China Based Biobanking Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biobanking Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biobanking Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biobanking Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biobanking Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biobanking Revenue Market Share (2021-2026)
Table 29. World Biobanking Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biobanking Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biobanking Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biobanking Market Size by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Table 33. World Biobanking Market Size Value by Storage Temperature Tier (2021-2026) & (USD Million)
Table 34. World Biobanking Market Size by Storage Temperature Tier (2027-2032) & (USD Million)
Table 35. World Biobanking Market Size by Research Focus, (USD Million), 2021 & 2025 & 2032
Table 36. World Biobanking Market Size Value by Research Focus (2021-2026) & (USD Million)
Table 37. World Biobanking Market Size by Research Focus (2027-2032) & (USD Million)
Table 38. World Biobanking Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Biobanking Market Size by Application (2021-2026) & (USD Million)
Table 40. World Biobanking Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Major Business
Table 43. Thermo Fisher Biobanking Product and Services
Table 44. Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Recent Developments/Updates
Table 46. Thermo Fisher Competitive Strengths & Weaknesses
Table 47. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 48. Beckman Coulter Major Business
Table 49. Beckman Coulter Biobanking Product and Services
Table 50. Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Beckman Coulter Recent Developments/Updates
Table 52. Beckman Coulter Competitive Strengths & Weaknesses
Table 53. Panasonic Basic Information, Manufacturing Base and Competitors
Table 54. Panasonic Major Business
Table 55. Panasonic Biobanking Product and Services
Table 56. Panasonic Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Panasonic Recent Developments/Updates
Table 58. Panasonic Competitive Strengths & Weaknesses
Table 59. SOL Group Basic Information, Manufacturing Base and Competitors
Table 60. SOL Group Major Business
Table 61. SOL Group Biobanking Product and Services
Table 62. SOL Group Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. SOL Group Recent Developments/Updates
Table 64. SOL Group Competitive Strengths & Weaknesses
Table 65. Promega Basic Information, Manufacturing Base and Competitors
Table 66. Promega Major Business
Table 67. Promega Biobanking Product and Services
Table 68. Promega Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Promega Recent Developments/Updates
Table 70. Promega Competitive Strengths & Weaknesses
Table 71. Merck Basic Information, Manufacturing Base and Competitors
Table 72. Merck Major Business
Table 73. Merck Biobanking Product and Services
Table 74. Merck Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Merck Recent Developments/Updates
Table 76. Merck Competitive Strengths & Weaknesses
Table 77. Greiner Bio One Basic Information, Manufacturing Base and Competitors
Table 78. Greiner Bio One Major Business
Table 79. Greiner Bio One Biobanking Product and Services
Table 80. Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Greiner Bio One Recent Developments/Updates
Table 82. Greiner Bio One Competitive Strengths & Weaknesses
Table 83. Kryosphere Basic Information, Manufacturing Base and Competitors
Table 84. Kryosphere Major Business
Table 85. Kryosphere Biobanking Product and Services
Table 86. Kryosphere Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Kryosphere Recent Developments/Updates
Table 88. Kryosphere Competitive Strengths & Weaknesses
Table 89. Precision for Medicine Basic Information, Manufacturing Base and Competitors
Table 90. Precision for Medicine Major Business
Table 91. Precision for Medicine Biobanking Product and Services
Table 92. Precision for Medicine Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Precision for Medicine Recent Developments/Updates
Table 94. Precision for Medicine Competitive Strengths & Weaknesses
Table 95. Azenta Basic Information, Manufacturing Base and Competitors
Table 96. Azenta Major Business
Table 97. Azenta Biobanking Product and Services
Table 98. Azenta Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Azenta Recent Developments/Updates
Table 100. Azenta Competitive Strengths & Weaknesses
Table 101. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 102. QIAGEN Major Business
Table 103. QIAGEN Biobanking Product and Services
Table 104. QIAGEN Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. QIAGEN Recent Developments/Updates
Table 106. QIAGEN Competitive Strengths & Weaknesses
Table 107. Vigilant Bioservices Basic Information, Manufacturing Base and Competitors
Table 108. Vigilant Bioservices Major Business
Table 109. Vigilant Bioservices Biobanking Product and Services
Table 110. Vigilant Bioservices Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Vigilant Bioservices Recent Developments/Updates
Table 112. Vigilant Bioservices Competitive Strengths & Weaknesses
Table 113. Lifeline Scientific Basic Information, Manufacturing Base and Competitors
Table 114. Lifeline Scientific Major Business
Table 115. Lifeline Scientific Biobanking Product and Services
Table 116. Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Lifeline Scientific Recent Developments/Updates
Table 118. Lifeline Scientific Competitive Strengths & Weaknesses
Table 119. Masy BioServices Basic Information, Manufacturing Base and Competitors
Table 120. Masy BioServices Major Business
Table 121. Masy BioServices Biobanking Product and Services
Table 122. Masy BioServices Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Masy BioServices Recent Developments/Updates
Table 124. Masy BioServices Competitive Strengths & Weaknesses
Table 125. Global Key Players of Biobanking Upstream (Raw Materials)
Table 126. Global Biobanking Typical Customers
Table 1. World Biobanking Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Table 2. World Biobanking Revenue by Region (2021-2026) & (USD Million), (by Headquarter Location)
Table 3. World Biobanking Revenue by Region (2027-2032) & (USD Million), (by Headquarter Location)
Table 4. World Biobanking Revenue Market Share by Region (2021-2026), (by Headquarter Location)
Table 5. World Biobanking Revenue Market Share by Region (2027-2032), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Biobanking Consumption Value Growth Rate Forecast by Region (2021 & 2025 & 2032) & (USD Million)
Table 8. World Biobanking Consumption Value by Region (2021-2026) & (USD Million)
Table 9. World Biobanking Consumption Value Forecast by Region (2027-2032) & (USD Million)
Table 10. World Biobanking Revenue by Player (2021-2026) & (USD Million)
Table 11. Revenue Market Share of Key Biobanking Players in 2025
Table 12. World Biobanking Industry Rank of Major Player, Based on Revenue in 2025
Table 13. Global Biobanking Company Evaluation Quadrant
Table 14. Head Office of Key Biobanking Players
Table 15. Biobanking Market: Company Product Type Footprint
Table 16. Biobanking Market: Company Product Application Footprint
Table 17. Biobanking Mergers & Acquisitions Activity
Table 18. United States VS China Biobanking Revenue Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 19. United States VS China Biobanking Consumption Value Comparison, (2021 & 2025 & 2032) & (USD Million)
Table 20. United States Based Biobanking Companies, Headquarters (States, Country)
Table 21. United States Based Companies Biobanking Revenue, (2021-2026) & (USD Million)
Table 22. United States Based Companies Biobanking Revenue Market Share (2021-2026)
Table 23. China Based Biobanking Companies, Headquarters (Province, Country)
Table 24. China Based Companies Biobanking Revenue, (2021-2026) & (USD Million)
Table 25. China Based Companies Biobanking Revenue Market Share (2021-2026)
Table 26. Rest of World Based Biobanking Companies, Headquarters (Province, Country)
Table 27. Rest of World Based Companies Biobanking Revenue (2021-2026) & (USD Million)
Table 28. Rest of World Based Companies Biobanking Revenue Market Share (2021-2026)
Table 29. World Biobanking Market Size by Type, (USD Million), 2021 & 2025 & 2032
Table 30. World Biobanking Market Size Value by Type (2021-2026) & (USD Million)
Table 31. World Biobanking Market Size by Type (2027-2032) & (USD Million)
Table 32. World Biobanking Market Size by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Table 33. World Biobanking Market Size Value by Storage Temperature Tier (2021-2026) & (USD Million)
Table 34. World Biobanking Market Size by Storage Temperature Tier (2027-2032) & (USD Million)
Table 35. World Biobanking Market Size by Research Focus, (USD Million), 2021 & 2025 & 2032
Table 36. World Biobanking Market Size Value by Research Focus (2021-2026) & (USD Million)
Table 37. World Biobanking Market Size by Research Focus (2027-2032) & (USD Million)
Table 38. World Biobanking Market Size by Application, (USD Million), 2021 & 2025 & 2032
Table 39. World Biobanking Market Size by Application (2021-2026) & (USD Million)
Table 40. World Biobanking Market Size by Application (2027-2032) & (USD Million)
Table 41. Thermo Fisher Basic Information, Manufacturing Base and Competitors
Table 42. Thermo Fisher Major Business
Table 43. Thermo Fisher Biobanking Product and Services
Table 44. Thermo Fisher Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 45. Thermo Fisher Recent Developments/Updates
Table 46. Thermo Fisher Competitive Strengths & Weaknesses
Table 47. Beckman Coulter Basic Information, Manufacturing Base and Competitors
Table 48. Beckman Coulter Major Business
Table 49. Beckman Coulter Biobanking Product and Services
Table 50. Beckman Coulter Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 51. Beckman Coulter Recent Developments/Updates
Table 52. Beckman Coulter Competitive Strengths & Weaknesses
Table 53. Panasonic Basic Information, Manufacturing Base and Competitors
Table 54. Panasonic Major Business
Table 55. Panasonic Biobanking Product and Services
Table 56. Panasonic Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 57. Panasonic Recent Developments/Updates
Table 58. Panasonic Competitive Strengths & Weaknesses
Table 59. SOL Group Basic Information, Manufacturing Base and Competitors
Table 60. SOL Group Major Business
Table 61. SOL Group Biobanking Product and Services
Table 62. SOL Group Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 63. SOL Group Recent Developments/Updates
Table 64. SOL Group Competitive Strengths & Weaknesses
Table 65. Promega Basic Information, Manufacturing Base and Competitors
Table 66. Promega Major Business
Table 67. Promega Biobanking Product and Services
Table 68. Promega Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 69. Promega Recent Developments/Updates
Table 70. Promega Competitive Strengths & Weaknesses
Table 71. Merck Basic Information, Manufacturing Base and Competitors
Table 72. Merck Major Business
Table 73. Merck Biobanking Product and Services
Table 74. Merck Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 75. Merck Recent Developments/Updates
Table 76. Merck Competitive Strengths & Weaknesses
Table 77. Greiner Bio One Basic Information, Manufacturing Base and Competitors
Table 78. Greiner Bio One Major Business
Table 79. Greiner Bio One Biobanking Product and Services
Table 80. Greiner Bio One Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 81. Greiner Bio One Recent Developments/Updates
Table 82. Greiner Bio One Competitive Strengths & Weaknesses
Table 83. Kryosphere Basic Information, Manufacturing Base and Competitors
Table 84. Kryosphere Major Business
Table 85. Kryosphere Biobanking Product and Services
Table 86. Kryosphere Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 87. Kryosphere Recent Developments/Updates
Table 88. Kryosphere Competitive Strengths & Weaknesses
Table 89. Precision for Medicine Basic Information, Manufacturing Base and Competitors
Table 90. Precision for Medicine Major Business
Table 91. Precision for Medicine Biobanking Product and Services
Table 92. Precision for Medicine Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 93. Precision for Medicine Recent Developments/Updates
Table 94. Precision for Medicine Competitive Strengths & Weaknesses
Table 95. Azenta Basic Information, Manufacturing Base and Competitors
Table 96. Azenta Major Business
Table 97. Azenta Biobanking Product and Services
Table 98. Azenta Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 99. Azenta Recent Developments/Updates
Table 100. Azenta Competitive Strengths & Weaknesses
Table 101. QIAGEN Basic Information, Manufacturing Base and Competitors
Table 102. QIAGEN Major Business
Table 103. QIAGEN Biobanking Product and Services
Table 104. QIAGEN Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 105. QIAGEN Recent Developments/Updates
Table 106. QIAGEN Competitive Strengths & Weaknesses
Table 107. Vigilant Bioservices Basic Information, Manufacturing Base and Competitors
Table 108. Vigilant Bioservices Major Business
Table 109. Vigilant Bioservices Biobanking Product and Services
Table 110. Vigilant Bioservices Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 111. Vigilant Bioservices Recent Developments/Updates
Table 112. Vigilant Bioservices Competitive Strengths & Weaknesses
Table 113. Lifeline Scientific Basic Information, Manufacturing Base and Competitors
Table 114. Lifeline Scientific Major Business
Table 115. Lifeline Scientific Biobanking Product and Services
Table 116. Lifeline Scientific Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 117. Lifeline Scientific Recent Developments/Updates
Table 118. Lifeline Scientific Competitive Strengths & Weaknesses
Table 119. Masy BioServices Basic Information, Manufacturing Base and Competitors
Table 120. Masy BioServices Major Business
Table 121. Masy BioServices Biobanking Product and Services
Table 122. Masy BioServices Biobanking Revenue, Gross Margin and Market Share (2021-2026) & (USD Million)
Table 123. Masy BioServices Recent Developments/Updates
Table 124. Masy BioServices Competitive Strengths & Weaknesses
Table 125. Global Key Players of Biobanking Upstream (Raw Materials)
Table 126. Global Biobanking Typical Customers
LIST OF FIGURES
Figure 1. Biobanking Picture
Figure 2. World Biobanking Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biobanking Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biobanking Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biobanking Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 13. Biobanking Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biobanking Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biobanking by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biobanking Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biobanking Markets in 2025
Figure 27. United States VS China: Biobanking Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biobanking Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biobanking Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biobanking Market Size Market Share by Type in 2025
Figure 31. Blood
Figure 32. Tissue
Figure 33. Cells
Figure 34. Other
Figure 35. World Biobanking Market Size Market Share by Type (2021-2032)
Figure 36. World Biobanking Market Size by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Figure 37. World Biobanking Market Size Market Share by Storage Temperature Tier in 2025
Figure 38. Ambient
Figure 39. 2–8°C Refrigerated
Figure 40. -20°C Freezer
Figure 41. -80°C ULT
Figure 42. Other
Figure 43. World Biobanking Market Size Market Share by Storage Temperature Tier (2021-2032)
Figure 44. World Biobanking Market Size by Research Focus, (USD Million), 2021 & 2025 & 2032
Figure 45. World Biobanking Market Size Market Share by Research Focus in 2025
Figure 46. Oncology
Figure 47. Immunology
Figure 48. Infectious Disease
Figure 49. Public Health
Figure 50. Metabolic
Figure 51. Other
Figure 52. World Biobanking Market Size Market Share by Research Focus (2021-2032)
Figure 53. World Biobanking Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Biobanking Market Size Market Share by Application in 2025
Figure 55. Life Sciences and Medicine
Figure 56. Hospitals
Figure 57. Research Institutions
Figure 58. Other
Figure 59. World Biobanking Market Size Market Share by Application (2021-2032)
Figure 60. Biobanking Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
Figure 1. Biobanking Picture
Figure 2. World Biobanking Total Revenue: 2021 & 2025 & 2032, (USD Million)
Figure 3. World Biobanking Total Revenue (2021-2032) & (USD Million)
Figure 4. World Biobanking Revenue by Region (2021, 2025 and 2032) & (USD Million), (by Headquarter Location)
Figure 5. World Biobanking Revenue Market Share by Region (2021-2032), (by Headquarter Location)
Figure 6. United States Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 7. China Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 8. Europe Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 9. Japan Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 10. South Korea Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 11. ASEAN Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 12. India Based Company Biobanking Revenue (2021-2032) & (USD Million)
Figure 13. Biobanking Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 16. World Biobanking Consumption Value Market Share by Region (2021-2032)
Figure 17. United States Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 18. China Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 19. Europe Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 20. Japan Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 21. South Korea Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 22. ASEAN Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 23. India Biobanking Consumption Value (2021-2032) & (USD Million)
Figure 24. Producer Shipments of Biobanking by Player Revenue ($MM) and Market Share (%): 2025
Figure 25. Global Four-firm Concentration Ratios (CR4) for Biobanking Markets in 2025
Figure 26. Global Four-firm Concentration Ratios (CR8) for Biobanking Markets in 2025
Figure 27. United States VS China: Biobanking Revenue Market Share Comparison (2021 & 2025 & 2032)
Figure 28. United States VS China: Biobanking Consumption Value Market Share Comparison (2021 & 2025 & 2032)
Figure 29. World Biobanking Market Size by Type, (USD Million), 2021 & 2025 & 2032
Figure 30. World Biobanking Market Size Market Share by Type in 2025
Figure 31. Blood
Figure 32. Tissue
Figure 33. Cells
Figure 34. Other
Figure 35. World Biobanking Market Size Market Share by Type (2021-2032)
Figure 36. World Biobanking Market Size by Storage Temperature Tier, (USD Million), 2021 & 2025 & 2032
Figure 37. World Biobanking Market Size Market Share by Storage Temperature Tier in 2025
Figure 38. Ambient
Figure 39. 2–8°C Refrigerated
Figure 40. -20°C Freezer
Figure 41. -80°C ULT
Figure 42. Other
Figure 43. World Biobanking Market Size Market Share by Storage Temperature Tier (2021-2032)
Figure 44. World Biobanking Market Size by Research Focus, (USD Million), 2021 & 2025 & 2032
Figure 45. World Biobanking Market Size Market Share by Research Focus in 2025
Figure 46. Oncology
Figure 47. Immunology
Figure 48. Infectious Disease
Figure 49. Public Health
Figure 50. Metabolic
Figure 51. Other
Figure 52. World Biobanking Market Size Market Share by Research Focus (2021-2032)
Figure 53. World Biobanking Market Size by Application, (USD Million), 2021 & 2025 & 2032
Figure 54. World Biobanking Market Size Market Share by Application in 2025
Figure 55. Life Sciences and Medicine
Figure 56. Hospitals
Figure 57. Research Institutions
Figure 58. Other
Figure 59. World Biobanking Market Size Market Share by Application (2021-2032)
Figure 60. Biobanking Industrial Chain
Figure 61. Methodology
Figure 62. Research Process and Data Source
